IFIH1 and clinically amyopathic dermatomyositis: The anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody was identified in 2005 to be associated with clinically amyopathic dermatomyositis (CADM) and rapidly progressive interstitial lung disease (RP-ILD) in adults [2, 3].